Methuselah Foundation

Last updated
Methuselah Foundation
Formation2000; 24 years ago, as the Performance Prize Society
Founders David Gobel
(co-founders Aubrey de Grey and Dane Gobel)
Type 501(c)(3)
Focus
Location
Area served
Global
Method
Executive Director
Sergio Ruiz
Website www.mfoundation.org

The Methuselah Foundation is an American-based global non-profit organization based in Springfield, Virginia, with a declared mission to "make 90 the new 50 by 2030" by supporting tissue engineering and regenerative medicine therapies. [1] The organization was originally incorporated by David Gobel in 2001 as the Performance Prize Society, a name inspired by the British governments Longitude Act, which offered monetary rewards for anyone who could devise a portable, practical solution for determining a ship's longitude.

Contents

Founding

In 2003, David Gobel, Aubrey de Grey, [2] and Dane Gobel rebranded the organization Methuselah Foundation, named after Methuselah, the grandfather of Noah in the Hebrew Bible, whose lifespan was recorded as 969 years.

The new name was introduced at the 32nd Annual Meeting of the American Aging Association, [3] where they awarded the first Methuselah Mouse Prize to Andrej Bartke for his work on mice that lived the equivalent of 180 human years. [4]

The Foundation's work includes:

Throughout its history, the Foundation has helped to reshape the perception of longevity research with the public and the scientific community. When it was launched, the field of longevity science was largely thought to be a playground for eccentrics. [9] Today, anti-aging or longevity research exists in the scientific mainstream and represents a $7 trillion dollar marketplace. [10]

All of the Foundation's grants, investments, prizes and policy decisions follow seven strategies: [11]

Current projects

Methuselah Funds

The Methuselah Funds (M Fund) was created in 2017 as an LLC subsidiary of the Methuselah Foundation to incubate and invest in early-stage companies. [5]

The entity operates as the mechanism through which the Foundation turns its vision into reality by identifying young companies whose research promises to transform the human lifespan, providing them with seed funds to underwrite their work and supporting them with ongoing business counsel. In this way, M Fund operates much like a business incubator to help young startups focus and build, and a business accelerator to help more mature organizations develop or acquire the resources needed to sustain their growth.

Strategic counsel is typically provided by Foundation Founder and M Fund CEO David Gobel and M Fund Co-Founder and Managing Director Sergio Ruiz.

Like traditional venture funds, the M Fund aims to maximize the business success of a portfolio company inline with strategic liquidity events. However, unlike those organizations, it is primarily focused on maximizing what it calls “return on mission,” which it defines as extending the healthy human lifespan. As such, the M Fund strives to support real-world products and therapies that can help any patient come to market. Through the years, Gobel and Ruiz have led investments in:

Nasa Challenge Partnerships

In 2016, NASA in partnership with the New Organ Alliance announced the Vascular Tissue Challenge. [24] [25] Creating a sufficient blood vessel system – vasculature – is often seen by biomedical researchers as a primary impediment in engineering thick tissues. The Vascular Tissue Challenge offers a $500,000 prize "to be divided among the first three teams that successfully create thick, metabolically-functional human vascularized organ tissue in a controlled laboratory environment." Two teams were awarded prizes for their breakthrough work in 2021. [26]

In November 2016, in conjunction with the Vascular Tissue Challenge, the New Organ Alliance hosted at the NASA Research Park the Vascular Tissue Challenge Roadmapping Workshop, with funding from the NSF.

In 2021, Methuselah announced that a second collaboration with NASA, the Deep Space Food Challenge, awarded $25,000 prizes to each of the 18 U.S. teams that designed a novel food production technology concept that maximizes safe, nutritious and palatable food outputs for long-duration space missions. [27] The competition has entered a second round, in which teams must actually build their technology. [28] [29]

Alliance for Longevity Initiatives

The Alliance for Longevity Initiatives, whose mission is to create social and political action around the issue of combating age-related chronic conditions and increasing our number of healthy, disease-free years. [30] The organization seeks to build policies that encourage economic and scientific support for more longevity solutions, such as bioengineered patient trials and dramatically improved biomedical research models that use engineered human tissue.

New Parts for People

Methuselah Foundation contributed $1Million to the Albert Einstein College of Medicine to fund development. Aging is a leading risk factor for most common neurodegenerative diseases, including strokes, brain tumors, aneurysms, cognitive impairments and dementias. [31]

Past projects

3D bioprinter grants

In 2013, Methuselah Foundation began a partnership with Organovo to fund the use of their 3D bioprinters at academic research centers for biomedical research. [32] Under the grant program, the foundation committed "at least $500,000 in direct funding for research projects across several institutions." [33] The first recipients were Yale School of Medicine, [34] UCSF School of Medicine, [35] and the Murdoch Children's Research Institute. [36]

Methuselah Mouse Prize

The Methuselah Mouse Prize (Mprize) was created to increase scientific and public interest in longevity research by awarding two cash prizes: "one to the research team that broke the world record for the oldest-ever mouse; and one to the team that developed the most successful late-onset rejuvenation strategy." The Mprize was announced publicly in 2003 by David Gobel and Aubrey de Grey at the American Aging Association. The prize for longevity was first won by a research team led by Andrzej Bartke of Southern Illinois University. The prize for rejuvenation first went to Stephen Spindler of the University of California, Riverside. Additionally, in 2009, the first Mprize Lifespan Achievement Award went to Z. Dave Sharp of the University of Texas Health Science Center at San Antonio for extending the lifespan of already aged mice using the pharmaceutical rapamycin. In May 2014, at the 43rd Annual Meeting of the American Aging Association, Methuselah Foundation awarded a $10,000 Mprize to Huber Warner for his founding of the National Institute on Aging's Interventions Testing Program.

Bowhead whale genome

In 2015, with funding from the Methuselah Foundation and Life Extension Foundation, the bowhead whale genome was sequenced by João Pedro de Magalhães and his team at the University of Liverpool. [37] The bowhead whale is possibly the longest-lived mammal, capable of living over 200 years. [38] The genome project was undertaken to learn more about the mammal's mechanisms for longevity and resistance to age-related diseases, which are unknown. [38] An assembly of the bowhead whale genome has been made available online to promote further research. [39]

New Organ Alliance

The Methuselah Foundation fiscally sponsors the New Organ Alliance, an initiative aimed at raising awareness and facilitating research to help alleviate organ donation shortages. [40] [41] In 2013, the foundation announced the New Organ Liver Prize, a $1,000,000 award to the first team that can create a bioengineered or regenerative liver therapy for a "large mammal, enabling the host to recover in the absence of native liver function and survive three months with a normal lifestyle." [42] [43]

The initiative is held in partnership with the Organ Preservation Alliance. New Organ Alliance worked out a technology roadmap report for organ banking and bioengineering solutions to help address organ shortages. [44] The roadmap was developed through a workshop in May 2015 in Washington, D.C., along with a subsequent roundtable held by the Office of Science and Technology Policy. It is funded from the National Science Foundation [45] and Methuselah Foundation. Two follow-up perspectives were published, "The Promise of Organ and Tissue Preservation to Transform Medicine" [46] and "Bioengineering Priorities on a Path to Ending Organ Shortage". [47]

In 2016, NASA in partnership with the New Organ Alliance announced the Vascular Tissue Challenge. [24] [25] Creating a sufficient blood vessel system – vasculature – is often seen by biomedical researchers as a primary impediment in engineering thick tissues. [48] [49] The Vascular Tissue Challenge offers a $500,000 prize "to be divided among the first three teams that successfully create thick, metabolically-functional human vascularized organ tissue in a controlled laboratory environment." [50]

In November 2016, in conjunction with the Vascular Tissue Challenge, the New Organ Alliance hosted at the NASA Research Park the Vascular Tissue Challenge Roadmapping Workshop, with funding from the NSF. [51] [52]

Organ Preservation Alliance

In 2013, Methuselah began fiscally sponsoring and collaborating with the Organ Preservation Alliance, an initiative coordinating research and stakeholders for the preservation of tissues and organs. [2] [53] [54] [55] The organization's activities have included:

The Organ Preservation Alliance, an initiative coordinating research and stakeholders focused on the preservation of tissues and organs. In 2015, OPA became an independent Tax exempt non-profit organization.

Supercentenarian Research Foundation

In 2006, Methuselah contributed capital and fiscal sponsorship to launch the Supercentenarian Research Foundation (SRF). [2] SRF was formed to study why supercentenarians, people over 110 years of age, live longer than most, and why they die. [63] Eight autopsies of supercentenarians were conducted by SRF, with six indicating senile cardiac transthyretin amyloidosis at the time of death. With this disease, a defective protein "amasses in and clogs blood vessels, forcing the heart to work harder and eventually fail." [64] [65]

SENS Research Foundation

From 2003 to 2009, [2] Methuselah Foundation served as the backbone organization for the strategies for engineered negligible senescence (SENS) program, a long-term research framework developed by Aubrey de Grey. [66] The SENS program aims to prevent or reverse seven forms of molecular or cellular damage associated with aging. [67]

During that time, de Grey and David Gobel established SENS-related research programs on human bioremedial biology – "getting the crud out" in Methuselah's parlance [68] – at Rice University and Arizona State University. [6] The programs were the first use of environmental remediation principles directed at reversing "pollution" in human cells. [69] Additionally, Methuselah sponsored a series of SENS-focused roundtables and conferences, [70] and funded the writing of Ending Aging , co-authored by de Grey and Michael Rae.

Under de Grey's continued leadership, SENS spun out from Methuselah as the SENS Research Foundation in 2009. [2]

Monetary support

Due to the close relationship between the Methuselah Foundation and SENS Research Foundation and their common activities, there are sometimes misunderstandings about their budgets, directions, and amounts of donations which can be distributed between these organizations for various purposes.

In 2004, the Methuselah Foundation began a donor initiative called "The Methuselah 300" ("The 300"), [71] a community of philanthropic donors pledging $25,000 over 25 years, at a minimum of $1,000 annually, toward the organization. The initiative was named after the 300 Spartans who held the pass at Thermopylae in 480 BC during the Greco-Persian War. In addition, in 2015, the foundation began memorializing The 300 donors with a monument [72] at St. Thomas Island in the U.S. Virgin Islands.

On September 16, 2006, Peter Thiel, co-founder and former CEO of the online payments system PayPal, announced that he was pledging $3.5 million to the Methuselah Foundation and the SENS programs "to support scientific research into the alleviation and eventual reversal of the debilities caused by aging". [73]

In 2007, Justin Bonomo, a professional poker player, pledged 5% of his tournament winnings to SENS research. [74] [75]

In January 2018, the anonymous principal of the Pineapple Fund donated $1 million to the Methuselah Foundation, [76] in addition to $2 million donated to SENS Research Foundation. [77]

On May 12, 2021, Vitalik Buterin, a co-founder of ethereum and transhumanist, made a series of donations to the foundation. The three transfers, made minutes apart, contained 432 trillion Dogelon Mars, worth about $336 million at the time of transfer, [78] and two transfers of 1000 Ether in total, worth more than $2 million. [79]

Related Research Articles

Maximum life span is a measure of the maximum amount of time one or more members of a population have been observed to survive between birth and death. The term can also denote an estimate of the maximum amount of time that a member of a given species could survive between birth and death, provided circumstances that are optimal to that member's longevity.

<span class="mw-page-title-main">Tissue engineering</span> Biomedical engineering discipline

Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues. Tissue engineering often involves the use of cells placed on tissue scaffolds in the formation of new viable tissue for a medical purpose, but is not limited to applications involving cells and tissue scaffolds. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance, it can is considered as a field of its own.

<span class="mw-page-title-main">Aubrey de Grey</span> English author and biogerontologist (born 1963)

Aubrey David Nicholas Jasper de Grey is an English biomedical gerontologist. He is the author of The Mitochondrial Free Radical Theory of Aging (1999) and co-author of Ending Aging (2007). De Grey is known for his view that medical technology may enable human beings alive today not to die from age-related causes. As an amateur mathematician, he has contributed to the study of the Hadwiger–Nelson problem in geometric graph theory, making the first progress on the problem in over 60 years.

Strategies for engineered negligible senescence (SENS) is a range of proposed regenerative medical therapies, either planned or currently in development, for the periodic repair of all age-related damage to human tissue. These therapies have the ultimate aim of maintaining a state of negligible senescence in patients and postponing age-associated disease. SENS was first defined by British biogerontologist Aubrey de Grey. Many mainstream scientists believe that it is a fringe theory. De Grey later highlighted similarities and differences of SENS to subsequent categorization systems of the biology of aging, such as the highly influential Hallmarks of Aging published in 2013.

<span class="mw-page-title-main">Organ printing</span> Method of creating artificial organs

Organ printing utilizes techniques similar to conventional 3D printing where a computer model is fed into a printer that lays down successive layers of plastics or wax until a 3D object is produced. In the case of organ printing, the material being used by the printer is a biocompatible plastic. The biocompatible plastic forms a scaffold that acts as the skeleton for the organ that is being printed. As the plastic is being laid down, it is also seeded with human cells from the patient's organ that is being printed for. After printing, the organ is transferred to an incubation chamber to give the cells time to grow. After a sufficient amount of time, the organ is implanted into the patient.

Gregory Stock is an American biophysicist, best-selling author, biotech entrepreneur, and the former director of the Program on Medicine, Technology and Society at UCLA’s School of Medicine. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of today's revolutions in the life sciences and in information technology and computers.

Following is a list of topics related to life extension:

The following outline is provided as an overview of and topical guide to life extension:

<span class="mw-page-title-main">Anthony Atala</span> American bioengineer and urologist

Anthony Atala is an American bioengineer, urologist, and pediatric surgeon. He is the W.H. Boyce professor of urology, the founding director of the Wake Forest Institute for Regenerative Medicine, and the chair of the Department of Urology at Wake Forest School of Medicine in North Carolina. His work focuses on the science of regenerative medicine: "a practice that aims to refurbish diseased or damaged tissue using the body's own healthy cells".

<span class="mw-page-title-main">David Gobel</span> American philanthropist, entrepreneur, inventor and futurist

David Gobel is an American philanthropist, entrepreneur, inventor, and futurist. He is co-founder and CEO of the Methuselah Foundation, CEO of the Methuselah Fund, and one of the first to publicly advance the idea of longevity escape velocity, even before this term was formulated.

The SENS Research Foundation is a non-profit organization that does research programs and public relations work for the application of regenerative medicine to aging. It was founded in 2009, located in Mountain View, California, USA. The organization publishes its reports annually.

<span class="mw-page-title-main">3D bioprinting</span> Utilization of 3D printing to fabricate biomedical parts

Three dimensional (3D) bioprinting is the utilization of 3D printing–like techniques to combine cells, growth factors, bio-inks, and biomaterials to fabricate functional structures that were traditionally used for tissue engineering applications but in recent times have seen increased interest in other applications such as biosensing, and environmental remediation. Generally, 3D bioprinting utilizes a layer-by-layer method to deposit materials known as bio-inks to create tissue-like structures that are later used in various medical and tissue engineering fields. 3D bioprinting covers a broad range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to help research drugs and potential treatments. Nonetheless, translation of bioprinted living cellular constructs into clinical application is met with several issues due to the complexity and cell number necessary to create functional organs. However, innovations span from bioprinting of extracellular matrix to mixing cells with hydrogels deposited layer by layer to produce the desired tissue. In addition, 3D bioprinting has begun to incorporate the printing of scaffolds which can be used to regenerate joints and ligaments. Apart from these, 3D bioprinting has recently been used in environmental remediation applications, including the fabrication of functional biofilms that host functional microorganisms that can facilitate pollutant removal.

The Thiel Foundation is a private foundation created and funded by billionaire Peter Thiel, co-founder of PayPal and an early investor in Facebook.

<span class="mw-page-title-main">Maria Entraigues-Abramson</span>

Maria Entraigues-Abramson is an Argentine-American singer, composer, and actress, and is the Director of Development for the SENS Research Foundation.

Organovo is an early-stage medical laboratory and research company which designs and develops functional, three dimensional human tissue for medical research and therapeutic applications. Organovo was established in 2007 and is headquartered in San Diego, California. The company uses its internally developed NovoGen MMX Bioprinter for 3D bioprinting.

Regeneration in humans is the regrowth of lost tissues or organs in response to injury. This is in contrast to wound healing, or partial regeneration, which involves closing up the injury site with some gradation of scar tissue. Some tissues such as skin, the vas deferens, and large organs including the liver can regrow quite readily, while others have been thought to have little or no capacity for regeneration following an injury.

The Pineapple Fund was a philanthropic project by an anonymous individual which gave away 5,057 bitcoins to 60 charities. The amount was valued at $86 million in December 2017. Some of the themes supported were medical research, environmental conservation, human rights and psychedelic therapy.

<span class="mw-page-title-main">Microgravity bioprinting</span>

Microgravity bioprinting is the utilization of 3D bioprinting techniques under microgravity conditions to fabricate highly complex, functional tissue and organ structures. The zero gravity environment circumvents some of the current limitations of bioprinting on Earth including magnetic field disruption and biostructure retention during the printing process. Microgravity bioprinting is one of the initial steps to advancing in space exploration and colonization while furthering the possibilities of regenerative medicine.

The Wyss Institute for Biologically Inspired Engineering is a cross-disciplinary research institute at Harvard University focused on bridging the gap between academia and industry by drawing inspiration from nature's design principles to solve challenges in health care and the environment. It is focused on the field of biologically inspired engineering to be distinct from bioengineering and biomedical engineering. The institute also has a focus on applications, intellectual property generation, and commercialization.

Kelly Stevens is an American bioengineer and associate professor at the University of Washington. Her research considers the study and development of human platforms to understand and treat disease. She was named a Paul G. Allen Frontiers Fellow in 2022.

References

  1. ↑ Page " About Us " on the site of Methuselah Foundation (Retrieved 2021-04-06)
  2. 1 2 3 4 5 "Progress in SENS Rejuvenation Research Over the Past 15 Years". Fight Aging!. 2017-06-30.
  3. ↑ Gobel, D. (2004-07-01). "Methuselah Foundation". Rejuvenation Research. 7 (2): 154–159. doi:10.1089/1549168041553035. ISSN   1549-1684. PMID   15312303.
  4. ↑ "A Methuselah of Mice Dies in Lab". Huron Daily Tribune. 2003-01-16. – updated 2016-04-25
  5. 1 2 "Methuselah Foundation Launches Methuselah Fund". Fight Aging!. 2017-03-22.
  6. 1 2 Watkins, Jenn (2009-01-16). "Researchers seek to create 'fountain of youth'".
  7. ↑ "New Organ – NASA". neworgan.org. Archived from the original on 2018-12-31. Retrieved 2018-03-02.
  8. ↑ Williams, Matt. "History of Challenges: New Organ Prize (2013–present)". HeroX. Archived from the original on 2018-03-03. Retrieved 2018-03-02.
  9. ↑ Live Longer With Evolution? Evidence May Lie in Fruit Flies
  10. ↑ This Marketplace Is Over $7 Trillion And Rising – Seven New Products And Services This Consumer Will Need From Future Entrepreneurs
  11. ↑ What We Do to lengthen the healthy human lifespan
  12. ↑ "Silverstone Solutions". Archived from the original on 2014-05-24. Retrieved 2014-07-23.
  13. ↑ Page " The Approach " on the site of the company Oisin Biotechnologies
  14. ↑ Page " About Us " on the site of the company Leucadia Therapeutics
  15. ↑ "OncoSenX". OncoSenX. Retrieved 2022-04-20.
  16. ↑ "Volumetric". Volumetric. Retrieved 2022-04-20.
  17. ↑ "3D Systems Announces Acquisition of Volumetric Biotechnologies". 3D Systems. 2021-10-27. Retrieved 2022-04-20.
  18. ↑ "turn.bio". turn.bio. Retrieved 2022-04-20.
  19. ↑ "Our Company". Repair Biotechnologies. Retrieved 2022-04-20.
  20. ↑ "Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study". Repair Biotechnologies. 2021-03-03. Retrieved 2022-04-20.
  21. ↑ "About". Viscient Biosciences. Retrieved 2022-04-20.
  22. ↑ "About Us". X-Therma. Retrieved 2022-04-20.
  23. ↑ "Peripheral Neuropathy and Our Drug". WinSanTor. Retrieved 2022-05-20.
  24. 1 2 Weitering, Hanneke (2016-06-23). "NASA Seeks Lab-Grown Tissue for Space-Radiation Studies". Space.com.
  25. 1 2 Giges, Nancy S. (2016-10-30). "Growing Human Organs in Space". ASME.org.
  26. ↑ Teams Engineer Complex Human Tissues, Win Top Prizes in NASA Challenge
  27. ↑ "NASA Announces Winners of Deep Space Food Challenge". NASA . Archived from the original on 2023-05-24.
  28. ↑ Deep Space Food Challenge: NASA Offers $1 Million for Innovative Systems to Feed Tomorrow’s Astronauts
  29. ↑ Deep Space Food Challenge
  30. ↑ Why A4LI?
  31. ↑ Methuselah Foundation Gives Albert Einstein College of Medicine $1 Million to Develop Engineered Brain Tissue
  32. ↑ Kaelin, Brooke (2013-08-01). "Organovo and Methuselah Foundation Announce Funding of Bioprinting Research". 3D Printer World. Archived from the original on 2018-12-31. Retrieved 2018-03-02.
  33. ↑ "Press Release | Investors | Organovo". Organovo. 2013-07-24.
  34. ↑ Milkert, Heidi (2014-12-03). "Organovo and Yale Announce Collaboration on 3D Bioprinting for Organ Transplantion | 3DPrint.com | The Voice of 3D Printing / Additive Manufacturing". 3DPrint.com.
  35. ↑ Connors, Tarcy (2016-06-13). "Organovo, UCSF to Collaborate to Develop 3-D Bioprinted Tissue". San Diego Business Journal .
  36. ↑ Florance, Adam (2017-01-25). "Bioprinted kidneys". LabOnline.
  37. ↑ Feltman, Rachel (2015-01-06). "Researchers hope this whale's genes will help reverse human aging". Washington Post. ISSN   0190-8286 . Retrieved 2018-03-02.
  38. 1 2 Keane, Michael; et al. (2015-01-06). "Insights into the Evolution of Longevity from the Bowhead Whale Genome". Cell Reports. 10 (1): 112–122. doi:10.1016/j.celrep.2014.12.008. ISSN   2211-1247. PMC   4536333 . PMID   25565328.
  39. ↑ "The Bowhead Whale Genome Resource". www.bowhead-whale.org. Retrieved 2021-04-08.
  40. ↑ "New Organ Alliance". neworgan.org. Archived from the original on 2016-04-01. Retrieved 2018-03-02.
  41. ↑ Dvorsky, George (2015-02-02). "How We'll Finally Put An End To Organ Donation Shortages". io9.
  42. ↑ "New Organ Liver Prize". neworgan.org. Archived from the original on 2017-05-11. Retrieved 2018-03-02.
  43. ↑ Diep, Francie (2013-12-19). "Foundation Offers $1 Million Prize For A Bioengineered Liver". Popular Science.
  44. 1 2 "Solving Organ Shortage through Organ Banking and Bioengineering" (PDF). Retrieved 2021-03-29.
  45. ↑ "NSF Award Search: Award #1759748 – Bioengineering of Organs Road-Map Summit". nsf.gov. Retrieved 2018-03-02.
  46. 1 2 Giwa, Sebastian; et al. (June 7, 2017). "The promise of organ and tissue preservation to transform medicine". Nature Biotechnology. 35 (6): 530–542. doi:10.1038/nbt.3889. ISSN   1546-1696. PMC   5724041 . PMID   28591112.
  47. ↑ Tsukamoto, Ann; et al. (January 5, 2016). "Challenging Regeneration to Transform Medicine". Stem Cells Translational Medicine. 5 (1): 1–7. doi:10.5966/sctm.2015-0180. ISSN   2157-6564. PMC   4704880 . PMID   26607174.
  48. ↑ Kim, Joseph J.; Hou, Luqia; Huang, Ngan F. (2016-09-01). "Vascularization of Three-Dimensional Engineered Tissues for Regenerative Medicine Applications". Acta Biomaterialia. 41: 17–26. doi:10.1016/j.actbio.2016.06.001. ISSN   1742-7061. PMC   4969172 . PMID   27262741.
  49. ↑ Visconti, Richard P; Kasyanov, Vladimir; Gentile, Carmine; Zhang, Jing; Markwald, Roger R; Mironov, Vladimir (March 2010). "Towards organ printing: engineering an intra-organ branched vascular tree". Expert Opinion on Biological Therapy. 10 (3): 409–420. doi:10.1517/14712590903563352. ISSN   1471-2598. PMC   4580374 . PMID   20132061.
  50. ↑ Harbaugh, Jennifer (2016-06-06). "NASA's Centennial Challenges: Vascular Tissue Challenge". NASA. Retrieved 2018-03-02.
  51. ↑ "New Organ – VTC Workshop". neworgan.org. Archived from the original on 2017-03-05. Retrieved 2018-03-02.
  52. ↑ "NSF Award Search: Award #1642055 – Vascular Tissue Road-mapping Workshop & Micro-gravity Impact Roundtable". www.nsf.gov. Retrieved 2018-03-02.
  53. ↑ www.organpreservationalliance.org – site of the Organ Preservation Alliance
  54. ↑ Scudellari, Megan (2015-03-04). "U.S. Funds Efforts to Freeze Human Organs for Long-Term Storage". Scientific American.
  55. ↑ "The Future of Organ Banking". The Alliance of Advanced BioMedical Engineering. 2017-07-31.
  56. ↑ Brown, Alan (2017-08-21). "Breakthroughs Fuel Organ Banking Summit". The Alliance of Advanced BioMedical Engineering.
  57. ↑ Lewis, Jedediah K.; et al. (2016-04-01). "The Grand Challenges of Organ Banking: Proceedings from the first global summit on complex tissue cryopreservation". Cryobiology. 72 (2): 169–182. doi:10.1016/j.cryobiol.2015.12.001. ISSN   0011-2240. PMID   26687388.
  58. ↑ McDannell, Libby (2016-12-22). "White House Highlights AST's New Initiative with Organ Preservation Alliance". American Society of Transplantation.
  59. ↑ "Organs On-Demand:Vision-Setting Workshop on an Organ Banking 'Apollo Program'" (PDF). United States Military Academy. 2015-08-06.
  60. ↑ Young, Leslie (2017-06-08). "Researchers unite in global call to speed organ preservation progress". University of Alberta – Faculty of Engineering. Archived from the original on 2017-11-12.
  61. ↑ Scudellari, Megan (2017-12-12). "Core Concept: Cryopreservation aims to engineer novel ways to freeze, store, and thaw organs". Proceedings of the National Academy of Sciences. 114 (50): 13060–13062. doi: 10.1073/pnas.1717588114 . ISSN   0027-8424. PMC   5740646 . PMID   29233932.
  62. ↑ "The Military's Organ and Tissue Banking". 2015-01-27. Archived from the original on 2019-04-30.
  63. ↑ Page " Mission Statement " on the site of Supercentenarian Research Foundation
  64. ↑ Schneck, Andrea (2010-03-04). "Department of Pathology and Laboratory Medicine performs autopsy on 115-year-old woman to aid research". Daily Bruin .
  65. ↑ Leslie, Mitch (2008-09-26). "Searching for the Secrets of the Super Old". Science. 321 (5897): 1764–1765. doi:10.1126/science.321.5897.1764. ISSN   0036-8075. PMID   18818335. S2CID   8441658.
  66. ↑ de Grey, Aubrey D. N. J.; Ames, Bruce N.; Andersen, Julie K.; Bartke, Andrzej; Campisi, Judith; Heward, Christopher B.; McCarter, Roger J. M.; Stock, Gregory (April 2002). "Time to talk SENS: critiquing the immutability of human aging". Annals of the New York Academy of Sciences. 959 (1): 452–462, discussion 463–465. Bibcode:2002NYASA.959..452G. doi:10.1111/j.1749-6632.2002.tb02115.x. ISSN   0077-8923. PMID   11976218. S2CID   1940908.
  67. ↑ "A Reimagined Research Strategy for Aging". SENS Research Foundation. 2012-11-18. Retrieved 2021-04-08.
  68. ↑ Page " About Us " on the site of Methuselah Fund (Retrieved 2021-04-08)
  69. ↑ Rittmann, Bruce E.; Schloendorn, John (2007-08-20). "Engineering Away Lysosomal Junk: Medical Bioremediation". Rejuvenation Research. 10 (3): 359–366. doi:10.1089/rej.2007.0594. ISSN   1549-1684. PMID   17708688.
  70. ↑ "SENS Conferences". SENS Research Foundation. 2016-02-08. Retrieved 2018-03-02.
  71. ↑ "The Methuselah 300". www.mfoundation.org. Archived from the original on 2018-03-03. Retrieved 2018-03-02.
  72. ↑ "The Methuselah 300 Monument is Unveiled". Fight Aging!. 2015-11-24. Retrieved 2018-03-02.
  73. ↑ Davidson, Keay (2006-09-18). "BAY AREA / Entrepreneur backs research on anti-aging / Scientist says humans could live indefinitely". San Francisco Chronicle . Retrieved 2021-03-29.
  74. ↑ "The Redemption of ZeeJustin". ESPN.com. 2007-02-22. Retrieved 2018-04-26.
  75. ↑ "Please Welcome the Newest Members of The Three Hundred". Methuselah Foundation Blog. Methuselah Foundation. 2007-01-18. Archived from the original on 2009-03-03. Retrieved 2009-03-14.
  76. ↑ "The Pineapple Fund Donates Millions to the Organ Preservation Alliance and Methuselah Foundation". Fight Aging!. 2018-01-29. Retrieved 2018-03-02.
  77. ↑ "Blockchain.com Explorer | BTC | ETH | BCH". www.blockchain.com.
  78. ↑ "Ethereum Creator, Vitalik Buterin, Donates Over $1B to India COVID Relief". TheStreet. 12 May 2021. Retrieved 29 May 2021.
  79. ↑ "Vitalik Buterin Donates More than $2 Million to the Methuselah Foundation". Fight Aging!. 17 May 2021. Retrieved 28 May 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.